about
A case of pharmacokinetic interference in comedication of clozapine and valproic acid.ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder[D3 agonism: an augmentative treatment in tardive dyskinesia? A case report].Sexual dysfunction related to psychotropic drugs: a critical review. Part III: mood stabilizers and anxiolytic drugs.Sexual dysfunction related to drugs: a critical review. Part IV: cardiovascular drugs.Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs.Incidence of seclusion and restraint in psychiatric hospitals: a literature review and survey of international trends.The association between suicide and the utilization of mental health services in South Tirol, Italy: a psychological autopsy study.Sexual dysfunction related to psychotropic drugs: a critical review part II: antipsychotics.Sexual dysfunction related to psychotropic drugs: a critical review--part I: antidepressants.On the significance of electroconvulsive therapy in the treatment of severe mental diseases.Seizure Adequacy Markers and the Prediction of Electroconvulsive Therapy Response.Risky use and misuse of alcohol and cigarettes in psychiatric inpatients: a screening questionnaire study.Differences among South Tyrolean suicides: a psychological autopsy study.Zuclopenthixol-acetate treatment in catatonic patients: the implication of iron metabolism.MTHFR: Genetic variants, expression analysis and COMT interaction in major depressive disorder.Bio-psycho-social Aspects of an Overall Treatment PlanSocioeconomic risk factors and depressive symptoms in alcohol use disorders among male suicides in South Tirol, Italy.Low frequency rTMS as an add-on antidepressive strategy: heterogeneous impact on 99mTc-HMPAO and 18 F-FDG uptake as measured simultaneously with the double isotope SPECT technique. Pilot study.Effect of chronic repetitive transcranial magnetic stimulation on regional cerebral blood flow and regional cerebral glucose uptake in drug treatment-resistant depressives. A brief report.A fast and feasible microextraction by packed sorbent (MEPS) procedure for HPLC analysis of the atypical antipsychotic ziprasidone in human plasma.[Teachers and attention deficit and/or hyperactivity disorder: a pilot study on the situation of teachers in Tyrol].Etomidate vs. thiopentone in electroconvulsive therapy. An interdisciplinary challenge for anesthesiology and psychiatry.Simultaneous pattern of rCBF and rCMRGlu in continuation ECT: case reports.Differential impairment of interhemispheric transmission in bipolar disease.Antidepressant-associated mania with escitalopram.[Generation y: problematic consequences for psychiatry and psychotherapy - pro & contra].A case of delayed galactorrhoea as an adverse event of overlapping haloperidol and clozapine administration.Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy.Clinical efficacy and cognitive side effects of bifrontal versus right unilateral electroconvulsive therapy (ECT): a short-term randomised controlled trial in pharmaco-resistant major depression.Combining high and low frequencies in rTMS antidepressive treatment: preliminary results.Post-traumatic stress disorder and amygdala-hippocampectomy.Repetitive transcranial magnetic stimulation in a patient with atypical Todd's postepileptic paralysis.Therapeutic drug monitoring in Italian psychiatry.Preliminary findings of simultaneous 18F-FDG and 99mTc-HMPAO SPECT in patients with depressive disorders at rest: differential correlates with ratings of anxiety.Combining nefazodone and midazolam during ECT.Repetitive transcranial magnetic stimulation in bulimia nervosa: preliminary results of a single-centre, randomised, double-blind, sham-controlled trial in female outpatients.Impact of seizure duration in maintenance electroconvulsive therapy.[Adverse cognitive effects and ECT].TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians<sup/>.
P50
Q31810188-243D2843-0BE6-4EA7-8FE1-549DF4354518Q34417778-D8DB132D-0EEB-4502-8576-C7E12BBADB01Q34592407-EBD4CA79-FC38-4671-A868-7674D85B8CB4Q35039846-5002925D-7F83-47FD-8435-3E02FA2FB51EQ35432458-8EC20888-54AC-48C0-A35C-FED3D88D9650Q35841676-165BF6D3-2F19-41B2-A17C-DFFC8EE1AAD1Q37591230-EC78FF91-CCED-49A7-87F3-85589CFAA47DQ38053294-8638DCAE-7BE8-41E6-9E07-371081F0E1DFQ38112069-0F39544D-73F4-4936-9AE5-D69CCAD3537DQ38112070-6641CB1E-6005-4600-8A86-948F209EACF1Q38366976-91CF0B02-84D6-4852-BC8F-090F59E65405Q38591397-DA91B14D-073B-43AD-A552-BF6FD6C4E037Q39394754-1CCDE28F-B75D-4D89-905E-CF57D9DECF23Q40346628-1FCF5DE1-EAB7-42A6-84BA-48FC0F4174B0Q40563119-3BF61BFD-C6F3-499E-91F2-09B3175191A0Q40892445-945B973B-6C22-4788-AFE0-9C6FD4159FD9Q42331764-495B7167-9891-4551-8377-2661C6ED216BQ42868902-51485047-6798-47CF-8358-5ADE6A61D199Q43688013-EDF70FF0-BC9B-4552-9056-1AA8CD900D83Q43861681-35648A85-0388-46B7-93E0-C50BCB3B046EQ43968210-1DFFAD1A-4874-4040-9335-C97F82770F0AQ44339657-E21033B6-259B-41C4-A422-773E398912FFQ44477910-00F26995-C00D-47F5-B07F-83849468F344Q44658970-4CA2272E-851A-4FDA-9034-DB64C66A912AQ44894140-689BD661-E2DB-4489-9789-B53D96D5EF2AQ45124173-EBAAC744-E4DE-4E77-BACC-77BD00A798D8Q45283705-106C8D74-CFD2-467D-9F79-5F864C0E062DQ46454548-7DEC3FDC-0AA3-467A-84B7-0FEEF089759AQ46588846-1D341E07-C6F5-4E77-B596-AC02B60DC396Q48323442-F533B118-378C-4021-A3E2-154E3ED70F4FQ48454270-4E4DDACD-B115-45A5-AA3E-99ED660E7FDAQ48568121-524285ED-C6C9-4C44-A4A5-974246F772B2Q49140016-5628BA42-879E-4BFF-B127-E0408FE2A14EQ50785097-A9BB7AB3-ACF6-43AD-94E1-135FD5268026Q51082337-6F84F321-AA6B-4396-AB34-4AE7A45066E3Q51432335-33873492-371B-4313-A8EC-C1A81B3489FDQ51723319-E3615654-292A-4B00-8A09-52DA7C1A6A99Q51858990-DF9359A2-6A7C-43E1-9BEB-476CD40D17F5Q51981199-6605754A-D266-4584-A5F6-39160326DF5EQ52808821-A383E457-2DED-4009-A1E6-8D433566A1AE
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andreas Conca
@ast
Andreas Conca
@en
Andreas Conca
@es
Andreas Conca
@nl
type
label
Andreas Conca
@ast
Andreas Conca
@en
Andreas Conca
@es
Andreas Conca
@nl
prefLabel
Andreas Conca
@ast
Andreas Conca
@en
Andreas Conca
@es
Andreas Conca
@nl
P1053
K-1499-2016
P106
P1153
55178948300
P21
P31
P3829
P496
0000-0003-4841-7510